Universität zu Köln

Journal Article

Chyla, Brenda, Stilgenbauer, Stephan, Eichhorst, Barbara, Schetelig, Johannes, Munir, Talha, Hillmen, Peter, Seymour, John F., Roberts, Andrew W., Coutre, Steven, Jurczak, Wojciech, Mulligan, Stephen P., Puvvada, Soham, Wendtner, Clemens, Davids, Matthew S., Boettcher, Sebastian, Cerri, Elisa, Zhou, Lang, Popovic, Relja, Poteracki, Mia, Arzt, Jennifer, Kim, Su Young, Verdugo, Maria, Bhathena, Anahita, Wierda, William and Hallek, Michael (2017). Venetoclax in relapsed/refractory chronic lymphocytic leukemia (CLL) with 17p deletion: outcome and minimal residual disease from the full population of the pivotal M13-982 trial. Leuk. Lymphoma, 58. S. 234 - 236. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Davids, Matthew S., Hallek, Michael, Wierda, William, Roberts, Andrew W., Stilgenbauer, Stephan, Jones, Jeffrey A., Gerecitano, John F., Kim, Su Young, Potluri, Jalaja, Busman, Todd, Best, Andrea, Verdugo, Maria E., Cerri, Elisa, Desai, Monali, Hillmen, Peter and Seymour, John F. (2018). Comprehensive Safety Analysis of Venetoclax Monotherapy for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia. Clin. Cancer Res., 24 (18). S. 4371 - 4380. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265

Kater, Arnon P., Shanafelt, Tait, Fischer, Kirsten and Wierda, William (2012). Highlights of the 6th Young Investigators' Meeting on chronic lymphocytic leukemia. Leuk. Lymphoma, 53 (11). S. 2312 - 2314. LONDON: INFORMA HEALTHCARE. ISSN 1042-8194

Rhodes, Joanna, Sail, Kavita, Yazdy, Maryam, Hill, Brian, Shadman, Mazyar, Tuncer, Hande H., Winter, Allison, Kennard, Kaitlin, Allan, John, Ujjani, Chaitra, Brander, Danielle, Cho, Sang Kyu, Sharmokh, Simon, Jiang, Dingfeng, Nabhan, Chadi, Barr, Paul ORCID: 0000-0002-9733-401X, Brown, Jennifer, Fox, Christopher, Schuh, Anna, Eyre, Toby, Lamanna, Nicole ORCID: 0000-0003-3331-9491, Wierda, William, Skarbnik, Alan, Roeker, Lindsey, Bannerji, Rajat, Evens, Andrew M., Pauff, James M., Schuster, Steven, Follows, George, Cheson, Bruce D., Eichhorst, Barbara and Mato, Anthony (2020). Factors impacting treatment selection in treatment-naive patients with CLL: a multicenter study. Leuk. Lymphoma, 61. S. 104 - 106. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Stilgenbauer, Stephan, Eichhorst, Barbara F., Schetelig, Johannes, Coutre, Steven, Seymour, John F., Munir, Talha, Puvvada, Soham D., Wendtner, Clemens-Martin, Roberts, Andrew W., Jurczak, Wojciech, Mulligan, Stephen, Boettcher, Sebastian, Mobasher, Mehrdad, Zhu, Ming, Chyla, Brenda, Verdugo, Maria, Enschede, Sari Heitner, Cerri, Elisa, Humerickhouse, Rod A., Gordon, Gary, Hallek, Michael and Wierda, William (2015). Venetoclax (ABT-199/GDC-0199) Monotherapy Induces Deep Remissions, Including Complete Remission and Undetectable MRD, in Ultra-High Risk Relapsed/Refractory Chronic Lymphocytic Leukemia with 17p Deletion: Results of the Pivotal International Phase 2 Study. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Wierda, William, Chyla, Brenda, Eichhorst, Barbara, Schetelig, Johannes, Munir, Talha, Hillmen, Peter, Seymour, John F., Roberts, Andrew W., Coutre, Steven, Jurczak, Wojciech, Mulligan, Stephen P., Wendtner, Clemens-Martin, Davids, Matthew, Boettcher, Sebastian, Cerri, Elisa, Zhou, Lang, Popovic, Relja, Poteracki, Mia, Arzt, Jennifer, Kim, Su Young, Verdugo, Maria, Bhathena, Anahita, Stilgenbauer, Stephan and Hallek, Michael (2017). Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) with 17p Deletion: Outcome and Minimal Residual Disease (MRD) from the Full Population of the Pivotal M13-982 Trial. Clin. Lymphoma Myeloma Leuk., 17. S. S303 - 1. DALLAS: CIG MEDIA GROUP, LP. ISSN 2152-2669